Fibrosarcoma of the Penis: Case Report and Review of the Literature

Wilson, Lawrence S.; Lockhart, Jorge L.; Bergman, Harry; Politano, Víctor A.

doi:10.1016/s0022-5347(17)52256-9

Cited by 10 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For this review of the literature, we identified 137 case reports with 269 total cases of hyperparathyroidism in pregnancy with the earliest case report published in 1947. There were 85 cases with a single report and 32 case series with the numbers of cases reported varying from 2 to 28 patients in each case report 1,3,5,10–143 …”

Section: Etiology Prevalence and Backgroundmentioning

confidence: 99%

Hyperparathyroidism in Pregnancy: A Review of the Literature

Strebeck¹,

Schneider²,

Whitcombe³

et al. 2022

Obstetrical &Amp; Gynecological Survey

View full text Add to dashboard Cite

ImportanceMaternal hyperparathyroidism can be associated with significant maternal and fetal morbidity and fetal mortality. Because the maternal symptoms are typically nonspecific, the disorder may not be recognized leading to adverse pregnancy outcomes.ObjectiveThe aim of this study was to review the literature on the etiology/prevalence, pathophysiology, diagnosis, management (medical and surgical), and the maternal/neonatal complications associated with pregnancies complicated by hyperparathyroidism.Evidence AcquisitionA literature search was undertaken by our university librarian using the search engines PubMed and Web of Science. Search terms used included “hyperparathyroidism” AND “pregnancy” OR “pregnancy complications” OR “maternal.” The number of years searched was not limited, but the abstracts had to be in English.ResultsThere were 309 abstracts identified, 164 of which are the basis of this review. This includes 137 articles of the 269 individual case reports in the literature since the first case report in 1947. The articles and case reports reviewed the etiology, risk factors, diagnosis, management, complications, and maternal/fetal outcomes of pregnancies complicated by hyperparathyroidism.Conclusions and RelevanceUndiagnosed maternal hyperparathyroidism can result in critical maternal and fetal outcomes during pregnancy. This review highlights what is currently known about hyperparathyroidism during pregnancy to increase the awareness of this serious pregnancy disorder.Target AudienceObstetricians and gynecologists, and family physiciansLearning ObjectivesAfter completing this activity, the learner should be better able to identify the causes of hyperparathyroidism in pregnancy; explain its pathophysiology; detect the nonspecific symptoms/conditions; evaluate the medical and surgical management; and describe the maternal and fetal complications.

show abstract

Section: Etiology Prevalence and Backgroundmentioning

confidence: 99%

Hyperparathyroidism in Pregnancy: A Review of the Literature

Strebeck¹,

Schneider²,

Whitcombe³

et al. 2022

Obstetrical &Amp; Gynecological Survey

View full text Add to dashboard Cite

show abstract

“…142 Other sarcomas of the penis are rare, but there have been reported cases of angiosarcomas, 144,145 epithelioid hemangioendotheliomas, 146,147 epithelioid sarcomas, 148,149 leiomyosarcomas, 150 undifferentiated pleomorphic sarcomas, 151,152 malignant schwannomas, 153,154 rhabdomyosarcomas, [155][156][157][158] and fibrosarcomas. [159][160][161]…”

Section: Basal Cell Carcinomamentioning

confidence: 99%

Malignant Tumors of the Penis

Brady

Mercurio

Brown

2013

Dermatologic Surgery

View full text Add to dashboard Cite

Physicians should be aware of the risk factors and clinical presentation of penile malignancies because early diagnosis is essential in effective management and cure. Accurate staging is imperative for risk stratification and treatment planning. Depending on the type of tumor, size of tumor, location, staging, and grading, treatment modalities vary and may include topical chemotherapy, surgical excision, Mohs micrographic surgery, laser excision or ablation, systemic chemotherapy, and radiotherapy.

show abstract